Evaluation of fibrosis in precision-cut tissue slices

Xenobiotica

Volumn 43, Issue 1, 2013, Pages 98-112

  Westra, I M ^a   Pham, B T ^a   Groothuis, G M M ^a   Olinga, P ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Antifibrotic drugs; Fibrosis; Precision cut tissue slices

Indexed keywords

ALCOHOL; GLIOTOXIN;

DISEASE MODEL; EVALUATION; HISTOPATHOLOGY; HUMAN; INTESTINAL FIBROSIS; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG FIBROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRECISION CUT TISSUE SLICE; REVIEW; TISSUE SLICE;

ANIMALS; FIBROSIS; HUMANS; MICRODISSECTION; MODELS, BIOLOGICAL; SPECIES SPECIFICITY; TISSUE CULTURE TECHNIQUES;

ANIMALIA;

EID: 84870525145     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2012.723151     Document Type: Review

References (176)

1. Adamson IY, Young L, Bowden DH. (1988). Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130: 377-383.
2. Agrez MV, Chua FK. (1990). The role of colon fibroblasts in malignant large bowel obstruction-an experimental in vitro model. Br J Cancer 62: 567-572.
3. Aukema HM, House JD, Bankovic-Calic N, Ogborn MR. (2004). Increased renal fibrosis and expression of renal phosphatidylinositol 4-kinase-β and phospholipase C (γ1) proteins in piglets exposed to ochratoxin-A. Nephron Physiol 96: P19-P25.
4. Azambuja E, Fleck JF, Batista RG, Menna Barreto SS. (2005). Bleomycin lung toxicity: who are the patients with increased risk? Pulm Pharmacol Ther 18: 363-366.
5. Barrett MC, Cashman SJ, Moss J. (1983). Experimental interstitial renal fibrosis in rats: nephritis induced by N-(3,5-dichlorophenyl) succinimide. Br J Exp Pathol 64: 425-436.
6. Barrett R, Zhang X, Koon HW, Vu M, Chang JY, Yeager N, Nguyen MA, Michelsen KS, Berel D, Pothoulakis C, Targan SR, Shih DQ. (2012). Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis. Am J Pathol 180: 636-649.
7. Barth K, Bläsche R, Kasper M. (2006). Lack of evidence for caveolin-1 and CD147 interaction before and after bleomycin-induced lung injury. Histochem Cell Biol 126: 563-573.
8. Basile DP, Leonard EC, Beal AG, Schleuter D, Friedrich J. (2012). Persistent oxidative stress following renal ischemia-reperfusion injury increases ANG II hemodynamic and fibrotic activity. Am J Physiol Renal Physiol 302: F1494-F1502.
9. Bataller R, Brenner DA. (2005). Liver fibrosis. J Clin Invest 115: 209-218.
10. Behrsing H, Amin K, Ip C, Tyson C. (2004). Induction of fibrosis by bleomycin and carmustine in rat lung slices. The Toxicologist 78: 50.
11. Beljaars L, Olinga P, Molema G, de Bleser P, Geerts A, Groothuis GM, Meijer DK, Poelstra K. (2001). Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA). Liver 21: 320-328.
12. Bonner JC. (2004). Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15: 255-273.
13. Boor P, Ostendorf T, Floege J. (2010). Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 6: 643-656.
14. Borowiec AM, Sydora BC, Doyle J, Guan LL, Churchill TA, Madsen K, Fedorak RN. (2012). Small bowel fibrosis and systemic inflammatory response after ileocolonic anastomosis in IL-10 null mice. J Surg Res (In Press).
15. Bruck R, Genina O, Aeed H, Alexiev R, Nagler A, Avni Y, Pines M. (2001). Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats. Hepatology 33: 379-386.
16. Burke JP, Watson RW, Murphy M, Docherty NG, Coffey JC, O'Connell PR. (2009). Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor β1-mediated activation of intestinal fibroblasts. Br J Surg 96: 541-551.
17. Campbell JS, Hughes SD, Gilbertson DG, Palmer TE, Holdren MS, Haran AC, Odell MM, Bauer RL, Ren HP, Haugen HS, Yeh MM, Fausto N. (2005). Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci USA 102: 3389-3394.
18. Chevalier RL, Forbes MS, Thornhill BA. (2009). Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 75: 1145-1152.
19. Clouzeau-Girard H, Guyot C, Combe C, Moronvalle-Halley V, Housset C, Lamireau T, Rosenbaum J, Desmoulière A. (2006). Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab Invest 86: 275-285.
20. Coker RK, Laurent GJ, Shahzeidi S, Lympany PA, du Bois RM, Jeffery PK, McAnulty RJ. (1997). Transforming growth factors-β 1, -β 2, and -β 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol 150: 981-991.
21. Cooper PR, Poll CT, Barnes PJ, Sturton RG. (2010). Involvement of IL-13 in tobacco smoke-induced changes in the structure and function of rat intrapulmonary airways. Am J Respir Cell Mol Biol 43: 220-226.
22. Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E. (2001). Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J Pathol 193: 538-545.
23. Czochra P, Klopcic B, Meyer E, Herkel J, Garcia-Lazaro JF, Thieringer F, Schirmacher P, Biesterfeld S, Galle PR, Lohse AW, Kanzler S. (2006). Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol 45: 419-428.
24. de Graaf IA, de Kanter R, de Jager MH, Camacho R, Langenkamp E, van de Kerkhof EG, Groothuis GM. (2006). Empirical validation of a rat in vitro organ slice model as a tool for in vivo clearance prediction. Drug Metab Dispos 34: 591-599.
25. De Kanter R, Monshouwer M, Draaisma AL, De Jager MH, de Graaf IA, Proost JH, Meijer DK, Groothuis GM. (2004). Prediction of whole-body metabolic clearance of drugs through the combined use of slices from rat liver, lung, kidney, small intestine and colon. Xenobiotica 34: 229-241.
26. de Kanter R, Tuin A, van de Kerkhof E, Martignoni M, Draaisma AL, de Jager MH, de Graaf IA, Meijer DK, Groothuis GM. (2005). A new technique for preparing precision-cut slices from small intestine and colon for drug biotransformation studies. J Pharmacol Toxicol Methods 51: 65-72.
27. Degryse AL, Tanjore H, Xu XC, Polosukhin VV, Jones BR, McMahon FB, Gleaves LA, Blackwell TS, Lawson WE. (2010). Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 299: L442-L452.
28. Deng ZY, Li J, Jin Y, Chen XL, Lü XW. (2009). Effect of oxymatrine on the p38 mitogen-activated protein kinases signalling pathway in rats with CCl4 induced hepatic fibrosis. Chin Med J 122: 1449-1454.
29. di Mola FF, Friess H, Scheuren A, Di Sebastiano P, Graber H, Egger B, Zimmermann A, Korc M, Büchler MW. (1999). Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease. Ann Surg 229: 67-75.
30. Dileto CL, Travis EL. (1996). Fibroblast radiosensitivity in vitro and lung fibrosis in vivo: comparison between a fibrosis-prone and fibrosisresistant mouse strain. Radiat Res 146: 61-67.
31. Donner CS. (1998). Pathophysiology and therapy of chronic radiationinduced injury to the colon. Dig Dis 16: 253-261.
32. Dooley S, ten Dijke P. (2012). TGF-ß in progression of liver disease. Cell Tissue Res 347: 245-256.
33. Farkas L, Farkas D, Ask K, Möller A, Gauldie J, Margetts P, Inman M, Kolb M. (2009). VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J Clin Invest 119: 1298-1311.
34. Fickert P, Stöger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H, Trauner M. (2007). A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol 171: 525-536.
35. Finkelstein JN, Johnston CJ, Baggs R, Rubin P. (1994). Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int J Radiat Oncol Biol Phys 28: 621-631.
36. Fiocchi C, Lund PK. (2011). Themes in fibrosis and gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol 300: G677-G683.
37. Fisher RL, Smith MS, Hasal SJ, Hasal KS, Gandolfi AJ, Brendel K. (1994). The use of human lung slices in toxicology. Hum Exp Toxicol 13: 466-471.
38. Flamant M, Placier S, Rodenas A, Curat CA, Vogel WF, Chatziantoniou C, Dussaule JC. (2006). Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease. J Am Soc Nephrol 17: 3374-3381.
39. Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R. (2010). Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 285: 20202-20212.
40. Freeman BA, O'Neil JJ. (1984). Tissue slices in the study of lung metabolism and toxicology. Environ Health Perspect 56: 51-60.
41. Friedman SL. (2003). Liver fibrosis - from bench to bedside. J Hepatol 38 Suppl 1: S38-S53.
42. Friedman SL. (2008). Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
43. Fritsch C, Simon-Assmann P, Kedinger M, Evans GS. (1997). Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine. Gastroenterology 112: 826-838.
44. Galicia-Moreno M, Favari L, Muriel P. (2012). Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model. Eur J Gastroenterol Hepatol 24: 179-185.
45. Geraci JP, Mariano MS. (1996). Radiation hepatology of the rat: association of the production of prostacyclin with radiationinduced hepatic fibrosis. Radiat Res 145: 93-97.
46. Ghosh AK, Vaughan DE. (2012). PAI-1 in tissue fibrosis. J Cell Physiol 227: 493-507.
47. Gonzalo T, Beljaars L, van de Bovenkamp M, Temming K, van Loenen AM, Reker-Smit C, Meijer DK, Lacombe M, Opdam F, Kéri G, OrfiL, Poelstra K, Kok RJ. (2007). Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells. J Pharmacol Exp Ther 321: 856-865.
48. Gross O, Girgert R, Beirowski B, Kretzler M, Kang HG, Kruegel J, Miosge N, Busse AC, Segerer S, Vogel WF, Müller GA, Weber M. (2010). Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix Biol 29: 346-356.
49. Gross TJ, Hunninghake GW. (2001). Idiopathic pulmonary fibrosis. N Engl J Med 345: 517-525.
50. Guarino M, Tosoni A, Nebuloni M. (2009). Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum Pathol 40: 1365-1376.
51. Guo Y, Wang H, Zhang C. (2007). Establishment of rat precision-cut fibrotic liver slice technique and its application in verapamil metabolism. Clin Exp Pharmacol Physiol 34: 406-413.
52. Guo Y, Wu XQ, Zhang C, Liao ZX, Wu Y, Wang H. (2012). Protective effect of sodium ferulate on acetaldehyde-treated precision-cut rat liver slices. J Med Food 15: 557-562.
53. Guyot C, Combe C, Balabaud C, Bioulac-Sage P, Desmoulière A. (2007a). Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices. J Hepatol 46: 142-150.
54. Guyot C, Combe C, Clouzeau-Girard H, Moronvalle-Halley V, Desmoulière A. (2007b). Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations. Virchows Arch 450: 503-512.
55. Guyot C, Lepreux S, Combe C, Sarrazy V, Billet F, Balabaud C, Bioulac- Sage P, Desmoulière A. (2010). Fibrogenic cell phenotype modifications during remodelling of normal and pathological human liver in cultured slices. Liver Int 30: 1529-1540.
56. Hagens WI, Beljaars L, Mann DA, Wright MC, Julien B, Lotersztajn S, Reker-Smit C, Poelstra K. (2008). Cellular targeting of the apoptosis-inducing compound gliotoxin to fibrotic rat livers. J Pharmacol Exp Ther 324: 902-910.
57. Hagens WI, Olinga P, Meijer DK, Groothuis GM, Beljaars L, Poelstra K. (2006). Gliotoxin non-selectively induces apoptosis in fibrotic and normal livers. Liver Int 26: 232-239.
58. Hart A, Mattheyse FJ, Balinsky JB. (1983). An organ culture of postnatal rat liver slices. In Vitro 19: 841-852.
59. Hayashi H, Sakai T. (2011). Animal models for the study of liver fibrosis: new insights from knockout mouse models. Am J Physiol Gastrointest Liver Physiol 300: G729-G738.
60. Haydont V, Vozenin-Brotons MC. (2007). Maintenance of radiationinduced intestinal fibrosis: cellular and molecular features. World J Gastroenterol 13: 2675-2683.
61. Hetzel M, Bachem M, Anders D, Trischler G, Faehling M. (2005). Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung 183: 225-237.
62. Hold GL, Untiveros P, Saunders KA, El-Omar EM. (2009). Role of host genetics in fibrosis. Fibrogenesis Tissue Repair 2: 6.
63. Homer RJ, Elias JA, Lee CG, Herzog E. (2011). Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med 135: 780-788.
64. Honzawa Y, Nakase H, Takeda Y, Nagata K, Chiba T. (2010). Heat shock protein 47 can be a new target molecule for intestinal fibrosis related to inflammatory bowel disease. Inflamm Bowel Dis 16: 2004-2006.
65. Hoyt DG, Lazo JS. (1992). Murine strain differences in acute lung injury and activation of poly(ADP-ribose) polymerase by in vitro exposure of lung slices to bleomycin. Am J Respir Cell Mol Biol 7: 645-651.
66. Inokuchi Y, Morohashi T, Kawana I, Nagashima Y, Kihara M, Umemura S. (2005). Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. Gut 54: 349-356.
67. Iredale JP. (2007). Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117: 539-548.
68. Johnson LA, Luke A, Sauder K, Moons DS, Horowitz JC, Higgins PD. (2012). Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in mice. Inflamm Bowel Dis 18: 460-471.
69. Johnston CJ, Williams JP, OkunieffP, Finkelstein JN. (2002). Radiationinduced pulmonary fibrosis: examination of chemokine and chemokine receptor families. Radiat Res 157: 256-265.
70. Kasper M, Seidel D, Knels L, Morishima N, Neisser A, Bramke S, Koslowski R. (2004). Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-β1. Histochem Cell Biol 121: 131-140.
71. Khan AA, Chow EC, Porte RJ, Pang KS, Groothuis GM. (2009). Expression and regulation of the bile acid transporter, OSTα-OSTβ in rat and human intestine and liver. Biopharm Drug Dispos 30: 241-258.
72. Kida H, Yoshida M, Hoshino S, Inoue K, Yano Y, Yanagita M, Kumagai T, Osaki T, Tachibana I, Saeki Y, Kawase I. (2005). Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288: L342-L349.
73. Kim EC, Zhu Y, Andersen V, Sciaky D, Cao HJ, Meekins H, Smith TJ, Lance P. (1998). Cytokine-mediated PGE2 expression in human colonic fibroblasts. Am J Physiol 275: C988-C994.
74. Kitamura H, Yamamoto S, Nakase H, Matsuura M, Honzawa Y, Matsumura K, Takeda Y, Uza N, Nagata K, Chiba T. (2011). Role of heat shock protein 47 in intestinal fibrosis of experimental colitis. Biochem Biophys Res Commun 404: 599-604.
75. Klassen LW, Thiele GM, Duryee MJ, Schaffert CS, DeVeney AL, Hunter CD, Olinga P, Tuma DJ. (2008). An in vitro method of alcoholic liver injury using precision-cut liver slices from rats. Biochem Pharmacol 76: 426-436.
76. Klein J, Kavvadas P, Prakoura N, Karagianni F, Schanstra JP, Bascands JL, Charonis A. (2011). Renal fibrosis: insight from proteomics in animal models and human disease. Proteomics 11: 805-815.
77. Kolb M, Margetts PJ, Galt T, Sime PJ, Xing Z, Schmidt M, Gauldie J. (2001). Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 163: 770-777.
78. KönigshoffM, Uhl F, Gosens R. (2011). From molecule to man: integrating molecular biology with whole organ physiology in studying respiratory disease. Pulm Pharmacol Ther 24: 466-470.
79. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. (1993). Interleukin- 10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
80. Lagaye S, Shen H, Saunier B, Nascimbeni M, Gaston J, Bourdoncle P, Hannoun L, Massault PP, Vallet-Pichard A, Mallet V, Pol S. (2012). Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection. Hepatology 56: 861-872.
81. Langberg CW, Hauer-Jensen M, Sung CC, Kane CJ. (1994). Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 32: 29-36.
82. Langberg CW, Sauer T, Reitan JB, Hauer-Jensen M. (1996). Relationship between intestinal fibrosis and histopathologic and morphometric changes in consequential and late radiation enteropathy. Acta Oncol 35: 81-87.
83. Lawrance IC, Maxwell L, Doe W. (2001). Inflammation location, but not type, determines the increase in TGF-β1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis 7: 16-26.
84. Lawrance IC, Wu F, Leite AZ, Willis J, West GA, Fiocchi C, Chakravarti S. (2003). A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology 125: 1750-1761.
85. Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, Yehualaeshet T, Lu B, Flavell RA, Milbrandt J, Homer RJ, Elias JA. (2004). Early growth response gene 1-mediated apoptosis is essential for transforming growth factor β1-induced pulmonary fibrosis. J Exp Med 200: 377-389.
86. Leonard F, Collnot EM, Lehr CM. (2010). A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. Mol Pharm 7: 2103-2119.
87. Levitsky J, Mailliard ME. (2004). Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 24: 233-247.
88. Ley K, Zarbock A. (2008). From lung injury to fibrosis. Nat Med 14: 20-21.
89. Lin CJ, Yang PC, Hsu MT, Yew FH, Liu TY, Shun CT, Tyan SW, Lee TC. (1998). Induction of pulmonary fibrosis in organ-cultured rat lung by cadmium chloride and transforming growth factor-β1. Toxicology 127: 157-166.
90. Linard C, Billiard F, Benderitter M. (2012). Intestinal irradiation and fibrosis in a Th1-deficient environment. Int J Radiat Oncol Biol Phys 84: 266-273.
91. Liu X, Sun SQ, Ostrom RS. (2005). Fibrotic lung fibroblasts show blunted inhibition by cAMP due to deficient cAMP response element-binding protein phosphorylation. J Pharmacol Exp Ther 315: 678-687.
92. Liu Y, Wen XM, Lui EL, Friedman SL, Cui W, Ho NP, Li L, Ye T, Fan ST, Zhang H. (2009). Therapeutic targeting of the PDGF and TGF-β- signaling pathways in hepatic stellate cells by PTK787/ZK22258. Lab Invest 89: 1152-1160.
93. Liu Y. (2011). Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696.
94. Liu Z, Huang XR, Lan HY. (2012). Smad3 mediates ANG II-induced hypertensive kidney disease in mice. Am J Physiol Renal Physiol 302: F986-F997.
95. Madtes DK, Elston AL, Hackman RC, Dunn AR, Clark JG. (1999). Transforming growth factor-α deficiency reduces pulmonary fibrosis in transgenic mice. Am J Respir Cell Mol Biol 20: 924-934.
96. Mahavadi S, Flynn RS, Grider JR, Qiao LY, Murthy KS, Hazelgrove KB, Kuemmerle JF. (2011). Amelioration of excess collagen IaI, fibrosis, and smooth muscle growth in TNBS-induced colitis in IGF-I (+/-) mice. Inflamm Bowel Dis 17: 711-719.
97. Mangum JB, Everitt JI, Bonner JC, Moore LR, Brody AR. (1990). Co-culture of primary pulmonary cells to model alveolar injury and translocation of proteins. In Vitro Cell Dev Biol 26: 1135-1143.
98. Margulis A, Nocka KH, Wood NL, Wolf SF, Goldman SJ, Kasaian MT. (2009). MMP dependence of fibroblast contraction and collagen production induced by human mast cell activation in a threedimensional collagen lattice. Am J Physiol Lung Cell Mol Physiol 296: L236-L247.
99. Martin M, Lefaix J, Delanian S. (2000). TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys 47: 277-290.
100. Melgert BN, Olinga P, Van Der Laan JM, Weert B, Cho J, Schuppan D, Groothuis GM, Meijer DK, Poelstra K. (2001). Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats. Hepatology 34: 719-728.
101. Moeller A, Ask K, Warburton D, Gauldie J, Kolb M. (2008). The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40: 362-382.
102. Moeller A, Rodriguez-Lecompte JC, Wang L, Gauldie J, Kolb M. (2006). Models of pulmonary fibrosis. Drug Discov Today Dis Models 3: 243-249.
103. Moodley YP, Misso NL, Scaffidi AK, Fogel-Petrovic M, McAnulty RJ, Laurent GJ, Thompson PJ, Knight DA. (2003). Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol 29: 490-498.
104. Moore BB, Hogaboam CM. (2008). Murine models of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L152-L160.
105. Mouratis MA, Aidinis V. (2011). Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med 17: 355-361.
106. Mourelle M, Salas A, Guarner F, Crespo E, García-Lafuente A, Malagelada Jr. A. (1998). Stimulation of transforming growth factor β1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology 114: 519-526.
107. Mulsow JJ, Watson RW, Fitzpatrick JM, O'Connell PR. (2005). Transforming growth factor-β promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. Ann Surg 242: 880-7, discussion 887.
108. Mutsaers SE, McAnulty RJ, Laurent GJ, Knight DA. (2004). Evaluation of experimental models of idiopathic pulmonary fibrosis. Drug Discov Today Dis Models 1: 329-336.
109. Nagae T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Saito Y, Ogawa Y, Kuwabara T, Tanaka I, Sugawara A, Kuwahara T, Nakao K. (2008). Adrenomedullin inhibits connective tissue growth factor expression, extracellular signal-regulated kinase activation and renal fibrosis. Kidney Int 74: 70-80.
110. Nakamura T, Akiyoshi H, Saito I, Sato K. (1999). Adenovirus-mediated gene expression in the septal cells of cirrhotic rat livers. J Hepatol 30: 101-106.
111. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. (1990). A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702.
112. Olinga P, Hof IH, Merema MT, Smit M, de Jager MH, Swart PJ, Slooff MJ, Meijer DK, Groothuis GM. (2001). The applicability of rat and human liver slices to the study of mechanisms of hepatic drug uptake. J Pharmacol Toxicol Methods 45: 55-63.
113. Olinga P, Merema M, Hof IH, de Jong KP, Slooff MJ, Meijer DK, Groothuis GM. (1998). Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metab Dispos 26: 5-11.
114. Pallottini V, Martini C, Bassi AM, Romano P, Nanni G, Trentalance A. (2006). Rat HMGCoA reductase activation in thioacetamideinduced liver injury is related to an increased reactive oxygen species content. J Hepatol 44: 368-374.
115. Parrish AR, Gandolfi AJ, Brendel K. (1995). Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci 57: 1887-1901.
116. Pham BT, Westra I, Oosterhuis D, de Graaf I, Olinga P. (2011). Rat and human intestinal slices as a model for intestinal fibrosis in inflammatory bowel disease. Inflamm Bowel Dis 17: S76-S76.
117. Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D. (2005). Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 43: 1045-1054.
118. Popov Y, Schuppan D. (2009). Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50: 1294-1306.
119. Possidente M, Dragoni S, Franco G, Gori M, Bertelli E, Teodori E, Frosini M, Valoti M. (2011). Rat intestinal precision-cut slices as an in vitro model to study xenobiotic interaction with transporters. Eur J Pharm Biopharm 79: 343-348.
120. Powell DW, Pinchuk IV, Saada JI, Chen X, Mifflin RC. (2011). Mesenchymal cells of the intestinal lamina propria. Annu Rev Physiol 73: 213-237.
121. Pucilowska JB, Williams KL, Lund PK. (2000). Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol 279: G653-G659.
122. Rahal K, Schmiedlin-Ren P, Adler J, Dhanani M, Sultani V, Rittershaus AC, Reingold L, Zhu J, McKenna BJ, Christman GM, Zimmermann EM. (2012). Resveratrol has antiinflammatory and antifibrotic effects in the peptidoglycan- polysaccharide rat model of Crohn's disease. Inflamm Bowel Dis 18: 613-623.
123. Ressmeyer AR, Larsson AK, Vollmer E, Dahlèn SE, Uhlig S, Martin C. (2006). Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur Respir J 28: 603-611
124. Richter KK, Fink LM, Hughes BM, Sung CC, Hauer-Jensen M. (1997). Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy? Radiother Oncol 44: 65-71.
125. Rieder F, Kessler SP, West GA, Bhilocha S, de la Motte C, Sadler TM, Gopalan B, Stylianou E, Fiocchi C. (2011). Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am J Pathol 179: 2660-2673.
126. Rigby RJ, Hunt MR, Scull BP, Simmons JG, Speck KE, Helmrath MA, Lund PK. (2009). A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora. Gut 58: 1104-1112.
127. San-Miguel B, Crespo I, Kretzmann NA, Mauriz JL, Marroni N, Tuñón MJ, González-Gallego J. (2010). Glutamine prevents fibrosis development in rats with colitis induced by 2,4,6-trinitrobenzene sulfonic acid. J Nutr 140: 1065-1071.
128. Schaffert CS, Duryee MJ, Bennett RG, DeVeney AL, Tuma DJ, Olinga P, Easterling KC, Thiele GM, Klassen LW. (2010). Exposure of precision-cut rat liver slices to ethanol accelerates fibrogenesis. Am J Physiol Gastrointest Liver Physiol 299: G661-G668.
129. Sellge G, Lorentz A, Gebhardt T, Levi-Schaffer F, Bektas H, Manns MP, Schuppan D, BischoffSC. (2004). Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor. J Immunol 172: 260-267.
130. Selman M, King TE, Pardo A; American Thoracic Society; European Respiratory Society; American College of Chest Physicians. (2001). Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151.
131. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. (1997). Adenovectormediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776.
132. Simmons JG, Pucilowska JB, Keku TO, Lund PK. (2002). IGF-I and TGF-β1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol 283: G809-G818.
133. Simon-Assmann P, Turck N, Sidhoum-Jenny M, Gradwohl G, Kedinger M. (2007). In vitro models of intestinal epithelial cell differentiation. Cell Biol Toxicol 23: 241-256.
134. Snowdon VK, Fallowfield JA. (2011). Models and mechanisms of fibrosis resolution. Alcohol Clin Exp Res 35: 794-799.
135. Speck KE, Garrison AP, Rigby RJ, von Allmen DC, Lund PK, Helmrath MA. (2011). Inflammation enhances resection-induced intestinal adaptive growth in IL-10 null mice. J Surg Res 168: 62-69.
136. Spottl T, Hausmann M, Gunckel M, Herfarth H, Herlyn M, Schoelmerich J, Rogler G. (2006). A new organotypic model to study cell interactions in the intestinal mucosa. Eur J Gastroenterol Hepatol 18: 901-909.
137. Starkel P, Leclercq IA. (2011). Animal models for the study of hepatic fibrosis. Best Pract Res Clin Gastroenterol 25: 319-333.
138. Strieter RM, Mehrad B. (2009). New mechanisms of pulmonary fibrosis. Chest 136: 1364-1370.
139. Suzuki K, Sun X, Nagata M, Kawase T, Yamaguchi H, Sukumaran V, Kawauchi Y, Kawachi H, Nishino T, Watanabe K, Yoneyama H, Asakura H. (2011). Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium. Pathol Int 61: 228-238.
140. Taguchi T, Razzaque MS. (2007). The collagen-specific molecular chaperone HSP47: is there a role in fibrosis? Trends Mol Med 13: 45-53.
141. te Velde AA, Verstege MI, Hommes DW. (2006). Critical appraisal of the current practice in murine TNBS-induced colitis. Inflamm Bowel Dis 12: 995-999.
142. Thannickal VJ, Toews GB, White ES, Lynch JP 3rd, Martinez FJ. (2004). Mechanisms of pulmonary fibrosis. Annu Rev Med 55: 395-417.
143. Tharaux PL, Chatziantoniou C, Fakhouri F, Dussaule JC. (2000). Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension 36: 330-336.
144. Theiss AL, Fuller CR, Simmons JG, Liu B, Sartor RB, Lund PK. (2005). Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation. Gastroenterology 129: 204-219.
145. Thieringer F, Maass T, Czochra P, Klopcic B, Conrad I, Friebe D, Schirmacher P, Lohse AW, Blessing M, Galle PR, Teufel A, Kanzler S. (2008). Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. Gene 423: 23-28.
146. Thrall RS, McCormick JR, Jack RM, McReynolds RA, Ward PA. (1979). Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin. Am J Pathol 95: 117-130.
147. Trojanowska M. (2008). Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatology (Oxford) 47 Suppl 5: 2-4.
148. Tsukada S, Parsons CJ, Rippe RA. (2006). Mechanisms of liver fibrosis. Clin Chim Acta 364: 33-60.
149. Tsukamoto H, Matsuoka M, French SW. (1990). Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10: 56-65.
150. Ueberham E, Löw R, Ueberham U, Schönig K, Bujard H, Gebhardt R. (2003). Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37: 1067-1078.
151. Umachandran M, Howarth J, Ioannides C. (2004). Metabolic and structural viability of precision-cut rat lung slices in culture. Xenobiotica 34: 771-780.
152. van de Bovenkamp M, Groothuis GM, Draaisma AL, Merema MT, Bezuijen JI, van Gils MJ, Meijer DK, Friedman SL, Olinga P. (2005). Precision-cut liver slices as a new model to study toxicity-induced hepatic stellate cell activation in a physiologic milieu. ToxicolSci 85: 632-638.
153. van de Bovenkamp M, Groothuis GM, Meijer DK, Olinga P. (2006a). Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro. J Hepatol 45: 696-703.
154. van de Bovenkamp M, Groothuis GMM, Meijer DKF, SlooffMJH, Olinga P. (2006b). Human liver slices as an in vitro model to study toxicityinduced hepatic stellate cell activation in a multicellular milieu. Chem Biol Interact 162: 62-69.
155. Van de Bovenkamp M, Groothuis GM, Meijer DK, Olinga P. (2007). Liver fibrosis in vitro: cell culture models and precision-cut liver slices. Toxicol In Vitro 21: 545-557.
156. van de Bovenkamp M, Groothuis GM, Meijer DK, Olinga P. (2008). Liver slices as a model to study fibrogenesis and test the effects of antifibrotic drugs on fibrogenic cells in human liver. Toxicol In Vitro 22: 771-778.
157. van de Kerkhof EG, de Graaf IAM, Ungell AB, Groothuis GMM. (2008). Induction of metabolism and transport in human intestine: validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro. Drug Metab Dispos 36: 604-613.
158. van Tol EA, Holt L, Li FL, Kong FM, Rippe R, Yamauchi M, Pucilowska J, Lund PK, Sartor RB. (1999). Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. Am J Physiol 277: G245-G255.
159. Veidal SS, Juul M, Leeming DJ, Karsdal MA. (2011). An ex vivo model for liver fibrosis resolution. Hepatology 54: 1219A-1219A.
160. Verrill C, Davies J, Millward-Sadler H, Sundstrom L, Sheron N. (2002). Organotypic liver culture in a fluid-air interface using slices of neonatal rat and adult human tissue - a model of fibrosis in vitro. J Pharmacol Toxicol Methods 48: 103-110.
161. Vickers AE, Fisher R, Olinga P, Dial S. (2011). Repair pathways evident in human liver organ slices. Toxicol In Vitro 25: 1485-1492.
162. Vickers AE, Fisher RL. (2005). Precision-cut organ slices to investigate target organ injury. Expert Opin Drug Metab Toxicol 1: 687-699.
163. Vickers AE, Fisher R, Olinga P. (2005). Human liver and kidney slice viability is extended and pathways of fibrosis are characterized. The Toxicologist 84: 1914.
164. Vickers AE, Saulnier M, Cruz E, Merema MT, Rose K, Bentley P, Olinga P. (2004). Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis. Toxicol Sci 82: 534-544.
165. Weiler-Normann C, Herkel J, Lohse AW. (2007). Mouse models of liver
166. Wengrower D, Zanninelli G, Latella G, Necozione S, Metanes I, Israeli E, Lysy J, Pines M, Papo O, Goldin E. (2012). Losartan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats. Can J Gastroenterol 26: 33-39.
167. Westra IM, Oosterhuis D, Groothuis GM, Olinga P. (2011). Induction of fibrotic markers in an in vitro model of liver fibrosis. Hepatology 54: 754A-755A.
168. Wilkening S, Stahl F, Bader A. (2003). Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 31: 1035-1042.
169. Wohlsen A, Martin C, Vollmer E, Branscheid D, Magnussen H, Becker WM, Lepp U, Uhlig S. (2003). The early allergic response in small airways of human precision-cut lung slices. Eur Respir J 21: 1024-1032.
170. Wynn TA. (2008). Cellular and molecular mechanisms of fibrosis. J Pathol 214: 199-210.
171. Wynn TA. (2011). Integrating mechanisms of pulmonary fibrosis. J Exp Med 208: 1339-1350.
172. Xie Y, Wang G, Wang H, Yao X, Jiang S, Kang A, Zhou F, Xie T, Hao H. (2012). Cytochrome P450 dysregulations in thioacetamideinduced liver cirrhosis in rats and the counteracting effects of hepatoprotective agents. Drug Metab Dispos 40: 796-802.
173. Xu X, Weksler-Zangen S, Pikarsky A, Pappo O, Wengrower D, BischoffSC, Pines M, Rivkind A, Goldin E, Levi-Schaffer F. (2002). Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis. Scand J Gastroenterol 37: 330-337.
174. Yoshida T, Arisaka Y, Nakagawa S, Takahashi H. (2004). Rotation culture with a newly developed holder enables long-term liver slice culture for study of liver fibrosis. Hepatol Res 28: 198-206.
175. Zeisberg M, Neilson EG. (2010). Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834.
176. Zeisberg M, Soubasakos MA, Kalluri R. (2005). Animal models of renal fibrosis. Methods Mol Med 117: 261-272.